Target type: cellularcomponent
The lipid bilayer surrounding an endolysosome. An endolysosome is a transient hybrid organelle formed by fusion of a late endosome with a lysosome. [GOC:pde]
The endolysosome membrane is a dynamic and complex structure that plays a crucial role in intracellular degradation and recycling. It is a composite membrane formed by the fusion of endosomes and lysosomes, and it contains a unique blend of proteins and lipids that reflect its diverse functions. Key features of the endolysosome membrane include:
- **Phospholipid bilayer:** Like all cellular membranes, the endolysosome membrane is composed of a phospholipid bilayer, providing structural integrity and separating the internal environment from the cytoplasm.
- **Integral membrane proteins:** These proteins are embedded within the phospholipid bilayer and contribute to diverse functions, including:
- **Proton pumps (e.g., V-ATPase):** Acidify the endolysosomal lumen, creating an acidic environment essential for the activity of hydrolytic enzymes.
- **Transporters:** Facilitate the transport of ions, nutrients, and other molecules across the membrane.
- **Receptors:** Bind to specific ligands, mediating endocytosis and subsequent intracellular trafficking.
- **SNARES:** Participate in membrane fusion events, allowing the endolysosome to fuse with other organelles like the Golgi apparatus or the plasma membrane.
- **Peripheral membrane proteins:** These proteins associate with the membrane surface, often interacting with integral membrane proteins. They play roles in:
- **Signal transduction:** Relaying information from the endolysosome to the cytoplasm, influencing cellular processes.
- **Regulation of enzyme activity:** Modulating the activity of hydrolytic enzymes within the endolysosomal lumen.
- **Lipid composition:** The endolysosome membrane exhibits a unique lipid composition compared to other cellular membranes. It is enriched in:
- **Phosphatidylinositol:** Plays a role in membrane trafficking and signal transduction.
- **Cholesterol:** Contributes to membrane fluidity and stability.
- **Sphingolipids:** Participate in membrane organization and signaling.
- **Hydrolytic enzymes:** The endolysosome lumen contains a cocktail of hydrolytic enzymes, including:
- **Proteases:** Break down proteins.
- **Nucleases:** Degrade nucleic acids.
- **Glycosidases:** Hydrolyze carbohydrates.
- **Lipases:** Digest lipids.
The composition and organization of the endolysosome membrane constantly evolve as the organelle matures and undergoes fusion events with other membrane-bound compartments. This dynamism is essential for the endolysosome to carry out its diverse roles in intracellular degradation, recycling, and signal transduction.'
"
Protein | Definition | Taxonomy |
---|---|---|
Toll-like receptor 7 | A Toll-like receptor 7 that is encoded in the genome of human. [PRO:CNA, UniProtKB:Q9NYK1] | Homo sapiens (human) |
Toll-like receptor 8 | A Toll-like receptor 8 that is encoded in the genome of human. [PRO:CNA, UniProtKB:Q9NR97] | Homo sapiens (human) |
Toll-like receptor 9 | A Toll-like receptor 9 that is encoded in the genome of human. [] | Homo sapiens (human) |
Proprotein convertase subtilisin/kexin type 9 | A proprotein convertase subtilisin/kexin type 9 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q8NBP7] | Homo sapiens (human) |
Low-density lipoprotein receptor | A low-density lipoprotein receptor that is encoded in the genome of human. [PRO:DNx, UniProtKB:P01130] | Homo sapiens (human) |
Toll-like receptor 7 | A Toll-like receptor 7 that is encoded in the genome of human. [PRO:CNA, UniProtKB:Q9NYK1] | Homo sapiens (human) |
Toll-like receptor 8 | A Toll-like receptor 8 that is encoded in the genome of human. [PRO:CNA, UniProtKB:Q9NR97] | Homo sapiens (human) |
Toll-like receptor 9 | A Toll-like receptor 9 that is encoded in the genome of human. [] | Homo sapiens (human) |
Proprotein convertase subtilisin/kexin type 9 | A proprotein convertase subtilisin/kexin type 9 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q8NBP7] | Homo sapiens (human) |
Low-density lipoprotein receptor | A low-density lipoprotein receptor that is encoded in the genome of human. [PRO:DNx, UniProtKB:P01130] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
hydroxychloroquine | hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions. Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970) | aminoquinoline; organochlorine compound; primary alcohol; secondary amino compound; tertiary amino compound | anticoronaviral agent; antimalarial; antirheumatic drug; dermatologic drug |
imiquimod | imiquimod : An imidazoquinoline fused [4,5-c] carrying isobutyl and amino substituents at N-1 and C-4 respectively. A prescription medication, it acts as an immune response modifier and is used to treat genital warts, superficial basal cell carcinoma, and actinic keratosis. Imiquimod: A topically-applied aminoquinoline immune modulator that induces interferon production. It is used in the treatment of external genital and perianal warts, superficial CARCINOMA, BASAL CELL; and ACTINIC KERATOSIS. | imidazoquinoline | antineoplastic agent; interferon inducer |
resiquimod | S 28463: structure given in first source | imidazoquinoline | |
s 1033 | (trifluoromethyl)benzenes; imidazoles; pyridines; pyrimidines; secondary amino compound; secondary carboxamide | anticoronaviral agent; antineoplastic agent; tyrosine kinase inhibitor | |
N'-[(4-chlorophenyl)-oxomethyl]-2-methyl-4-thiazolecarbohydrazide | carbonyl compound; organohalogen compound | ||
N'2-[3-(trifluoromethyl)benzoyl]-3-aminopyrazine-2-carbohydrazide | (trifluoromethyl)benzenes | ||
sm360320 | SM360320: Proc Natl Acad Sci U S A 2006 Feb 7;103(6):1828-33 | ||
cl 075 | |||
vtx-2337 | |||
dsr-6434 | DSR-6434: structure in first source | ||
gardiquimod | |||
gs-9620 | |||
PF-06446846 | PF-06446846 : A triazolopyridine that is 3H-[1,2,3]triazolo[4,5-b]pyridine substituted by a 4-{(3-chloropyridin-2-yl)[(3R)-piperidin-3-yl]carbamoyl}phenyl group at position 3. It is a potent inhibitor of PCSK9. PF-06446846: inhibits translation of PCSK9 ;structure in first source | benzamides; monochloropyridine; piperidines; tertiary carboxamide; triazolopyridine | antilipemic drug; EC 3.4.21.61 (kexin) inhibitor |